Distribuzione geografica
Continente #
EU - Europa 2089
NA - Nord America 1614
AS - Asia 775
SA - Sud America 32
OC - Oceania 31
AF - Africa 18
Continente sconosciuto - Info sul continente non disponibili 3
Totale 4562
Nazione #
US - Stati Uniti d'America 1538
GB - Regno Unito 688
IT - Italia 473
CN - Cina 382
SE - Svezia 207
DE - Germania 186
IE - Irlanda 86
IN - India 82
FR - Francia 79
JP - Giappone 70
TR - Turchia 65
BE - Belgio 64
CA - Canada 60
ES - Italia 53
DK - Danimarca 51
KR - Corea 35
NL - Olanda 32
CH - Svizzera 30
AU - Australia 26
NO - Norvegia 23
HK - Hong Kong 22
ID - Indonesia 22
VN - Vietnam 22
PH - Filippine 20
GR - Grecia 17
AT - Austria 15
PL - Polonia 15
UA - Ucraina 13
MX - Messico 11
PT - Portogallo 11
BR - Brasile 10
FI - Finlandia 9
IL - Israele 9
IR - Iran 9
TW - Taiwan 8
RO - Romania 7
RU - Federazione Russa 7
CZ - Repubblica Ceca 6
CL - Cile 5
CO - Colombia 5
EG - Egitto 5
LT - Lituania 5
NZ - Nuova Zelanda 5
PE - Perù 5
SC - Seychelles 5
TH - Thailandia 5
AR - Argentina 4
KE - Kenya 4
MO - Macao, regione amministrativa speciale della Cina 4
QA - Qatar 4
CY - Cipro 3
EU - Europa 3
RS - Serbia 3
SG - Singapore 3
BA - Bosnia-Erzegovina 2
CR - Costa Rica 2
HU - Ungheria 2
PK - Pakistan 2
SA - Arabia Saudita 2
VE - Venezuela 2
ZA - Sudafrica 2
AE - Emirati Arabi Uniti 1
AW - Aruba 1
BD - Bangladesh 1
BG - Bulgaria 1
EC - Ecuador 1
EE - Estonia 1
GT - Guatemala 1
HR - Croazia 1
IQ - Iraq 1
IS - Islanda 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MY - Malesia 1
NI - Nicaragua 1
RE - Reunion 1
TN - Tunisia 1
Totale 4562
Città #
Southend 608
Chandler 221
Milan 203
Seattle 155
Wilmington 99
Fairfield 88
Dublin 86
Princeton 74
Dearborn 62
Ann Arbor 58
Houston 57
Ashburn 45
Beijing 45
Istanbul 45
Cambridge 41
Grafing 37
Brussels 36
Woodbridge 36
Redwood City 30
Des Moines 29
Hanover 29
Guangzhou 27
Nanjing 27
Shenyang 27
London 25
Toronto 25
Phoenix 23
Berlin 22
Jinan 22
Shanghai 21
San Diego 19
Seoul 18
Hangzhou 15
Falls Church 14
Fremont 13
New York 12
Sunnyvale 12
Turin 12
Zhengzhou 12
Madrid 11
Amsterdam 10
Boardman 10
Frankfurt am Main 10
Genoa 10
Ottawa 10
Redmond 10
Rome 10
Tianjin 10
Tokyo 10
Central District 9
Oslo 9
Upper Marlboro 9
Central 8
Monza 8
San Giuliano Milanese 8
Barcelona 7
Dallas 7
Hebei 7
Montréal 7
Philadelphia 7
Rho 7
Taipei 7
Ankara 6
Boston 6
Chicago 6
Copenhagen 6
Haikou 6
Lisbon 6
Los Angeles 6
Molenbeek-Saint-Jean 6
Oxford 6
Paris 6
Pittsburgh 6
Rochester 6
Silver Spring 6
Sydney 6
Xian 6
Andover 5
Aurora 5
Baltimore 5
Bern 5
Changsha 5
Dong Ket 5
Fontenay-sous-bois 5
Hefei 5
Indianapolis 5
Kaunas 5
Mahé 5
Marseille 5
Medford 5
Montreal 5
Nagoya 5
Nanchang 5
Piscataway 5
Portland 5
São Paulo 5
Taizhou 5
Torino 5
Vienna 5
Warsaw 5
Totale 2836
Nome #
Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non-Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors 626
Fasting-Mimicking Diet Is Safe and Reshapes Metabolism and Antitumor Immunity in Patients with Cancer 588
Genomic and transcriptomic analyses of breast cancer primaries and matched metastases in AURORA, the Breast International Group (BIG) molecular screening initiative 305
Application of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trials 210
Transplantation of autologous extracellular vesicles for cancer-specific targeting 196
Cancer-derived EVs show tropism for tissues at early stage of neoplastic transformation 181
A cell-of-origin epigenetic tracer reveals clinically distinct subtypes of high-grade serous ovarian cancer 164
The Stearoyl-CoA desaturase1 (SCD) in Drosophila is necessary for Myc induced autophagy, a potential new link to tumor growth 146
Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in Invasive Breast Carcinoma and Ductal Carcinoma in Situ, Metastatic Tumor Deposits and Areas for Further Research 138
Endocrine-responsive lobular carcinoma of the breast: features associated with risk of late distant recurrence 134
Cancer Associated Fibroblasts and Senescent Thyroid Cells in the Invasive Front of Thyroid Carcinoma 125
Tumor-infiltrating lymphocytes (TILs) are a powerful prognostic marker in patients with triple-negative breast cancer enrolled in the IBCSG phase III randomized clinical trial 22-00 101
Effect of metformin on breast ductal carcinoma in situ proliferation in a randomized presurgical trial 100
Ductal carcinoma in situ and intraoperative partial breast irradiation: Who are the best candidates? Long-term outcome of a single institution series 95
Prognostic implications of residual disease tumor-infiltrating lymphocytes and residual cancer burden in triple negative breast cancer patients after neo-adjuvant chemotherapy 90
Towards mm-wave spectroscopy for dielectric characterization of breast surgical margins 90
Tumor Biomarkers for the Prediction of Distant Metastasis in Head and Neck Squamous Cell Carcinoma 90
Biomarkers for the identification of recurrence in human epidermal growth factor receptor 2-positive breast cancer patients 85
The clinical relevance of micropapillary carcinoma of the breast : a case-control study 80
Pulmonary squamous cell carcinoma with lepidic growth pattern : new insights into lung cancer classification 72
Assessing Tumor-infiltrating Lymphocytes in Solid Tumors : a Practical Review for Pathologists and Proposal for a Standardized Method from the International Immunooncology Biomarkers Working Group : Part 1 : Assessing the Host Immune Response, TILs in Invasive Breast Carcinoma and Ductal Carcinoma in Situ, Metastatic Tumor Deposits and Areas for Further Research 72
Prognostic value of tumour-infiltrating lymphocytes in small HER2-positive breast cancer 70
Tumor-infiltrating lymphocytes (TILs) in ER+/HER2− breast cancer 69
Retroperitoneal pararenal isolated neuro fibroma: report of a case and review of literature 68
Malignant salivary gland tumours in families with breast cancer susceptibility 68
The prevalence and clinical relevance of tumor-infiltrating lymphocytes (TILs) in ductal carcinoma in situ of the breast 67
Prognostic and predictive value of cell cycle progression (CCP) score in ductal carcinoma in situ of the breast 65
Oncological Outcomes of Nipple-Sparing Mastectomy : a Single-Center Experience of 1989 Patients 61
Tumour infiltrating lymphocytes (TILs) in breast cancer during pregnancy 60
Clinical validity of tumor-infiltrating lymphocytes analysis in patients with triple-negative breast cancer 53
The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group 52
Copy number alterations analysis of primary tumor tissue and circulating tumor cells from patients with early-stage triple negative breast cancer 51
Correlation between radiological and biological features and clinical outcomes in early prostate cancer: an exploratory subgroup analysis 46
ROS1 Gene Fusion in Advanced Lung Cancer in Women : A Systematic Analysis, Review of the Literature, and Diagnostic Algorithm 38
Blood-based genomics of triple-negative breast cancer progression in patients treated with neoadjuvant chemotherapy 28
Hormone receptor status influences the impact of body mass index and hyperglycemia on the risk of tumor relapse in early-stage HER2-positive breast cancer patients 28
Fatty acid uptake as a potentially new resistance mechanism to anti-HER2 treatments in HER2-positive breast cancer 25
Circulating Fatty Acid Profile as a Biomarker for Immunotherapy in Advanced Non-Small Cell Lung Cancer 24
Targeted-gene sequencing to catch triple negative breast cancer heterogeneity before and after neoadjuvant chemotherapy 20
Targeting lipid metabolism is an emerging strategy to enhance the efficacy of anti-HER2 therapies in HER2-positive breast cancer 18
MGMT inactivation as a new biomarker in patients with advanced biliary tract cancers 16
Case Report: Prolonged clinical benefit with sequential trastuzumab-containing treatments in a patient with advanced extramammary Paget disease of the groin 15
12P The RODILIA pilot study for molecular screening of patients with metaplastic breast cancer 14
Enhancer mapping uncovers phenotypic heterogeneity and evolution in patients with luminal breast cancer 13
Predictive role of CD36 expression in HER2-positive breast cancer patients receiving neoadjuvant trastuzumab 12
Acquired Resistance Mechanisms to PD-L1 Blockade in a Patient With Microsatellite Instability-High Extrahepatic Cholangiocarcinoma 11
Clinical outcomes and radio-biological features correlation in early pca: An exploratory analysis 11
Management of BRCA Tumour Testing in an Integrated Molecular Tumour Board Multidisciplinary Model 10
Moving HER2-low breast cancer predictive and prognostic data from clinical trials into the real world 10
Detection of genomically aberrant cells within circulating tumor microemboli (CTMs) isolated from early-stage breast cancer patients 9
Prognostic role of body mass index (BMI) in patients with Human Epidermal growth factor Receptor 2 (HER2)epositive early breast cancer treated with adjuvant trastuzumab-containing chemotherapy 9
Circulating Tumor Cell Clusters Are Frequently Detected in Women with Early-Stage Breast Cancer 9
Exceptional tumour responses to fasting-mimicking diet combined with standard anticancer therapies: A sub-analysis of the NCT03340935 trial 9
Prognostic significance of HER2-low status in HR-positive/HER2-negative advanced breast cancer treated with CDK4/6 inhibitors 8
Mammographic density to predict response to neoadjuvant systemic breast cancer therapy 8
Unfavorable prognostic role of tumor-infiltrating lymphocytes in hormone-receptor positive, HER2 negative metastatic breast cancer treated with metronomic chemotherapy 7
Analysis of Efficacy and Accuracy of 2 Vacuum-Assisted Breast Biopsy Devices: Mammotome and Elite 7
Clinical performance of contrast-enhanced spectral mammography in pre-surgical evaluation of breast malignant lesions in dense breasts: a single center study 6
Tumor infiltrating lymphocyte stratification of prognostic staging of early-stage triple negative breast cancer 6
The impact of COVID-19 on diagnosis of recurrent breast cancer 6
Ultra-deep multigene profiling of matched primary and metastatic hormone receptor positive breast cancer patients relapsed after adjuvant endocrine treatment reveals novel aberrations in the estrogen receptor pathway 6
Enhancers mapping uncovers phenotypic heterogeneity and evolution in patients with luminal breast cancer 5
Macrophage morphology and distribution are strong predictors of prognosis in resected colorectal liver metastases: results from an external retrospective observational study 5
Bridging therapeutic opportunities: a survey by the Italian molecular tumor board workgroup of Alliance Against Cancer 5
Hormone Receptor Loss in Breast Cancer: Molecular Mechanisms, Clinical Settings, and Therapeutic Implications 5
Targeted RNA-sequencing analysis for fusion transcripts detection in tumor diagnostics: assessment of bioinformatic tools reliability in FFPE samples 5
Prognostic implications of residual disease (RD) tumor-infiltrating lymphocytes (TIL) in triple negative breast cancer (TNBC) after neo-adjuvant chemotherapy (NAC) 5
Contrast-enhanced mammography in the evaluation of breast calcifications: preliminary experience 5
Innate immunity in colorectal liver metastases: macrophage morphology and distribution are strong predictors of prognosis: An external validation 4
The pathology report 4
Tumor infiltrating lymphocytes in early breast cancer 4
ESR1 gene amplification and MAP3K mutations are selected during adjuvant endocrine therapies in relapsing Hormone Receptor-positive, HER2-negative breast cancer (HR+ HER2- BC) 3
Tumor-Infiltrating Lymphocytes and Prognosis: A Pooled Individual Patient Analysis of Early-Stage Triple-Negative Breast Cancers 3
Primary tumor somatic mutations in the blood of women with ductal carcinoma in situ of the breast 3
Efficacy and Safety of First-line Carboplatin-paclitaxel and Carboplatin-gemcitabine in Patients With Advanced Triple-negative Breast Cancer: A Monocentric, Retrospective Comparison 3
End-of-neoadjuvant treatment circulating microRNAs and HER2-positive breast cancer patient prognosis: An exploratory analysis from NeoALTTO 3
Fatty acid synthase as a new therapeutic target for HER2-positive gastric cancer 3
Multigene signatures for early breast cancer in clinical practice: A report of the Lombardy genomic assays for breast cancer working group 3
Characterization of gene fusions in paired primary and metastatic samples of breast cancer in the AURORA molecular screening program 2
Solitary thyroid metastasis from colon cancer: A rare case report 1
Salivary gland choristoma in large bowel 1
First report of AURORA, the breast international group (BIG) molecular screening initiative for metastatic breast cancer (MBC) patients (pts) 1
A single-arm, open-label, multicenter, phase IIIb clinical trial with nivolumab in subjects with recurrent or metastatic platinum-refractory squamous cell carcinoma of the head and neck 1
TILs in ER+/HER2-breast cancer 1
64P Mammographic density to predict response to neoadjuvant chemotherapy for breast cancer 1
The developmental origins of high grade serous ovarian cancer 1
Totale 4878
Categoria #
all - tutte 8690
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8690

Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/201824 0000 00 00 00204
2018/2019537 4733124155 2026 3414 23152719
2019/2020543 6410443 5264 5833 100613519
2020/2021789 60472227 7379 7770 127974466
2021/2022990 84735157 7839 5075 17211365133
2022/20231738 160122149194 228371 12380 112601390
Totale 4878